Role of N6-Methyladenosine RNA Modification in Cardiovascular Disease
Despite treatments being improved and many risk factors being identified, cardiovascular disease (CVD) is still a leading cause of mortality and disability worldwide. N6-methyladenosine (m6A) is the most common, abundant, and conserved internal modification in RNAs and plays an important role in the...
Main Authors: | Dandan Song, Jianhua Hou, Junduo Wu, Junnan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.659628/full |
Similar Items
-
RNA N6-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications
by: Qin Dang, et al.
Published: (2021-06-01) -
N6-methyladenosine (m6A) modification in hepatocellular carcinoma
by: Hehua Ma, et al.
Published: (2024-04-01) -
Circular RNA expression profiles and bioinformatics analysis in ovarian endometriosis
by: Dandan Wang, et al.
Published: (2019-07-01) -
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
by: Xiaoge Hu, et al.
Published: (2022-07-01) -
The Novel Regulatory Role of the lncRNA–miRNA–mRNA Axis in Chronic Inflammatory Airway Diseases
by: Xin Qiao, et al.
Published: (2022-06-01)